标题
CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer
作者
关键词
-
出版物
Cell Death & Disease
Volume 12, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-27
DOI
10.1038/s41419-021-04027-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synthetic Lethal Screens Reveal Co-Targeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma
- (2021) Justine S. Paradis et al. CLINICAL CANCER RESEARCH
- Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors
- (2020) William Hankey et al. CANCER RESEARCH
- Targeting super-enhancer-associated oncogenes in osteosarcoma with THZ2, a covalent CDK7 inhibitor
- (2020) Jiajun Zhang et al. CLINICAL CANCER RESEARCH
- IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway
- (2020) Alex Bainbridge et al. NUCLEIC ACIDS RESEARCH
- Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
- (2020) Zeda Zhang et al. CANCER CELL
- Characterizing CDK12-Mutated Prostate Cancers
- (2020) Pasquale Rescigno et al. CLINICAL CANCER RESEARCH
- The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
- (2020) Szilvia Juhász et al. Science Advances
- NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells
- (2019) Elia Farah et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CDK 12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS 1‐ErbB‐ PI 3K signaling
- (2019) Hee‐Joo Choi et al. EMBO REPORTS
- CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma
- (2019) Cun Wang et al. GUT
- Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer
- (2019) Rachana Patel et al. CANCER RESEARCH
- Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
- (2018) Yi-Mi Wu et al. CELL
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression
- (2016) S. M. Lopez et al. CLINICAL CANCER RESEARCH
- Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
- (2016) Yan-Yi Jiang et al. GUT
- Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells
- (2016) KAMILA DOMIŃSKA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
- (2016) Tinghu Zhang et al. Nature Chemical Biology
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Cdk12 is essential for embryonic development and the maintenance of genomic stability
- (2015) H-C Juan et al. CELL DEATH AND DIFFERENTIATION
- Clinical Pharmacokinetic Studies of Enzalutamide
- (2015) Jacqueline A. Gibbons et al. CLINICAL PHARMACOKINETICS
- Super Enhancers in Cancers, Complex Disease, and Developmental Disorders
- (2015) Adrienne Niederriter et al. Genes
- Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
- (2014) Camilla L. Christensen et al. CANCER CELL
- CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
- (2014) Edmond Chipumuro et al. CELL
- Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures
- (2014) Wouter R. Karthaus et al. CELL
- Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer
- (2014) Z. Chen et al. EMBO JOURNAL
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
- (2014) Nicholas Kwiatkowski et al. NATURE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- (2013) Tim Wang et al. SCIENCE
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase II
- (2012) S.- W. G. Cheng et al. MOLECULAR AND CELLULAR BIOLOGY
- Triheteromeric N-methyl-d-aspartate receptors differentiate synaptic inputs onto pyramidal neurons in somatosensory cortex: Involvement of the GluN3A subunit
- (2012) J. Pilli et al. NEUROSCIENCE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes
- (2011) D. Blazek et al. GENES & DEVELOPMENT
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started